JP2014513122A5 - - Google Patents

Download PDF

Info

Publication number
JP2014513122A5
JP2014513122A5 JP2014509340A JP2014509340A JP2014513122A5 JP 2014513122 A5 JP2014513122 A5 JP 2014513122A5 JP 2014509340 A JP2014509340 A JP 2014509340A JP 2014509340 A JP2014509340 A JP 2014509340A JP 2014513122 A5 JP2014513122 A5 JP 2014513122A5
Authority
JP
Japan
Prior art keywords
optionally substituted
carboxamide
dihydroisoxazol
methoxybenzyl
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014509340A
Other languages
English (en)
Japanese (ja)
Other versions
JP6101250B2 (ja
JP2014513122A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/035832 external-priority patent/WO2012151158A1/en
Publication of JP2014513122A publication Critical patent/JP2014513122A/ja
Publication of JP2014513122A5 publication Critical patent/JP2014513122A5/ja
Application granted granted Critical
Publication of JP6101250B2 publication Critical patent/JP6101250B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014509340A 2011-04-30 2012-04-30 治療薬としてのイソオキサゾリン類 Expired - Fee Related JP6101250B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1272DE2011 2011-04-30
IN1272/DEL/2011 2011-04-30
PCT/US2012/035832 WO2012151158A1 (en) 2011-04-30 2012-04-30 Isoxazolines as therapeutic agents

Publications (3)

Publication Number Publication Date
JP2014513122A JP2014513122A (ja) 2014-05-29
JP2014513122A5 true JP2014513122A5 (enExample) 2015-06-25
JP6101250B2 JP6101250B2 (ja) 2017-03-22

Family

ID=47108012

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014509340A Expired - Fee Related JP6101250B2 (ja) 2011-04-30 2012-04-30 治療薬としてのイソオキサゾリン類

Country Status (24)

Country Link
US (2) US9029409B2 (enExample)
EP (1) EP2704712A4 (enExample)
JP (1) JP6101250B2 (enExample)
KR (1) KR20140041512A (enExample)
CN (1) CN103764145A (enExample)
AR (1) AR086113A1 (enExample)
AU (2) AU2012250979B2 (enExample)
CA (1) CA2834237A1 (enExample)
CL (1) CL2013003125A1 (enExample)
CO (1) CO6801765A2 (enExample)
CR (1) CR20130597A (enExample)
DO (1) DOP2013000251A (enExample)
EC (1) ECSP13013026A (enExample)
GT (1) GT201300267A (enExample)
IL (1) IL229081A0 (enExample)
MX (1) MX355996B (enExample)
MY (1) MY163870A (enExample)
PE (1) PE20141190A1 (enExample)
PH (2) PH12013502218A1 (enExample)
RU (1) RU2013152961A (enExample)
SG (1) SG194696A1 (enExample)
TW (1) TW201247657A (enExample)
UY (1) UY34043A (enExample)
WO (1) WO2012151158A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2922854T3 (pl) * 2012-11-21 2022-07-18 Zoetis Services Llc Synteza spirocyklicznych pochodnych izoksazoliny
AU2014315410A1 (en) * 2013-09-05 2016-03-03 Abbvie Inc. Diastereoselective methods for synthesizing isoxazole compounds
EP3325465B1 (en) * 2015-07-17 2022-05-18 Syngenta Participations AG Pesticidally active pyrazole derivatives
EP3145168A1 (en) 2015-09-17 2017-03-22 Thomson Licensing An apparatus and a method for generating data representing a pixel beam
CN111194316A (zh) * 2017-08-14 2020-05-22 勃林格殷格翰动物保健美国公司 农药的和杀寄生物的吡唑-异噁唑啉化合物
EP3847169A1 (en) * 2018-09-04 2021-07-14 F. Hoffmann-La Roche AG Benzothiazole compounds for the treatment of autoimmune diseases
JP2023541153A (ja) * 2020-09-14 2023-09-28 ジェンザイム・コーポレーション 鎌状赤血球症を処置するための、ビスホスホグリセリン酸ムターゼのモジュレーターとしてのカルボン酸含有化合物
JP2024518377A (ja) 2021-05-03 2024-05-01 カトリック ユニヴェルシテット ルーヴェン 薬剤耐性癲癇の治療

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090382A (en) 1996-02-09 2000-07-18 Basf Aktiengesellschaft Human antibodies that bind human TNFα
CO5170501A1 (es) 1999-04-14 2002-06-27 Novartis Ag AZOLES SUSTITUIDOS UTILES PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR TNFa eIL-1 Y ENFERMEDADES DEL METABOLISMO OSEO
ECSP003448A (es) 2000-04-27 2000-05-25 Azoles sustituidos
TW200812986A (en) 2002-08-09 2008-03-16 Nps Pharma Inc New compounds
US20040067985A1 (en) * 2002-10-04 2004-04-08 Fortuna Haviv Method of inhibiting angiogenesis
US7166609B2 (en) * 2002-11-02 2007-01-23 Sanofi-Aventis Deutschland Gmbh Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases
DK1560815T3 (da) 2002-11-02 2008-06-16 Sanofi Aventis Deutschland Nye pyrimidin-4,6-dicarboxylsyrediamider til selektiv inhibering af kollagenaser
US7125870B2 (en) * 2002-11-06 2006-10-24 Bristol-Myers Squibb Company Isoxazoline derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme
US20050004111A1 (en) * 2003-01-03 2005-01-06 Aventis Pharma Deutschland Gmbh Selective MMP-13 inhibitors
EP1694655A2 (en) 2003-11-26 2006-08-30 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
CN1933839A (zh) 2004-01-23 2007-03-21 安进公司 化合物和使用方法
CN1930136B (zh) * 2004-03-05 2012-02-08 日产化学工业株式会社 异*唑啉取代苯甲酰胺化合物及有害生物防除剂
DE102004023635A1 (de) 2004-05-10 2006-04-13 Grünenthal GmbH Heteroarylsubstituierte Cyclohexyl-1,4-diamin-Derivate
KR101436161B1 (ko) 2005-01-25 2014-09-01 신타 파마슈티칼스 코프. 염증 및 면역 관련 용도를 위한 화합물
AU2006281497B2 (en) 2005-08-15 2012-06-07 F. Hoffmann-La Roche Ag Piperidine and piperazine derivatives as P2X3 antagonists
US7964624B1 (en) 2005-08-26 2011-06-21 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases
CN101330828A (zh) * 2005-12-14 2008-12-24 杜邦公司 用于防治无脊椎害虫的异噁唑啉
US20090143410A1 (en) * 2005-12-14 2009-06-04 Kanu Maganbhai Patel Isoxazolines for Controlling Invertebrate Pests
JP2009519208A (ja) 2005-12-15 2009-05-14 塩野義製薬株式会社 アミド誘導体を含有する医薬組成物
WO2007079199A2 (en) * 2005-12-30 2007-07-12 Alantos Pharmaceuticals, Holding, Inc. Substituted bis-amide metalloprotease inhibitors
TWI412322B (zh) * 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
WO2007123855A2 (en) * 2006-04-20 2007-11-01 E. I. Du Pont De Nemours And Company Pyrazolines for controlling invertebrate pests
CN105622463B (zh) 2006-12-26 2019-02-22 兰休斯医疗成像公司 用于使心脏神经支配成像的配体
BRPI0809770B8 (pt) * 2007-06-13 2022-12-06 Du Pont Composto e composição para controlar uma praga de invertebrados
US20090035381A1 (en) 2007-08-01 2009-02-05 Stankus John J Electrospraying method for fabrication of particles and coatings and treatment methods thereof
CN101815710A (zh) 2007-08-02 2010-08-25 美国辉瑞有限公司 嘧啶和吡啶衍生物及其药物应用和组合物
CN101778833A (zh) 2007-08-10 2010-07-14 日本曹达株式会社 含氮杂环化合物和有害生物防除剂
EP2185337A4 (en) 2007-09-12 2014-12-03 Univ Washington PROCESS FOR BLOWING CELLULAR THERMOPLASTIC SOLIDS
US8461185B2 (en) 2007-10-31 2013-06-11 Merck Sharp & Dohme Corp. P2X3 receptor antagonists for treatment of pain
TWI411395B (zh) * 2007-12-24 2013-10-11 Syngenta Participations Ag 殺蟲化合物
JP2009286773A (ja) * 2008-03-14 2009-12-10 Bayer Cropscience Ag 殺虫性縮環式アリール類
NZ588954A (en) 2008-05-01 2012-08-31 Vitae Pharmaceuticals Inc Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
HUE028347T2 (en) 2008-06-10 2016-12-28 Abbvie Inc Tricyclic compounds
WO2010010187A1 (en) 2008-07-25 2010-01-28 Galapagos Nv Novel compounds useful for the treatment of degenerative and inflammatory diseases
EP2331536B1 (en) * 2008-08-22 2013-08-21 Syngenta Participations AG Insecticidal compounds
WO2010045191A2 (en) 2008-10-13 2010-04-22 Vuelogic, Llc Methods and systems for customer performance scoring
EP2344480A1 (en) 2008-10-15 2011-07-20 Boehringer Ingelheim International GmbH Fused heteroaryl diamide compounds useful as mmp-13 inhibitors
CA2741666C (en) 2008-10-31 2017-04-11 Merck Sharp & Dohme Corp. P2x3, receptor antagonists for treatment of pain
NZ593135A (en) * 2008-12-19 2013-04-26 Novartis Ag Isoxazoline derivatives and their use as pesticide
US20110288089A1 (en) * 2009-01-22 2011-11-24 Syngenta Crop Protection Llc Insecticidal compounds
JP2012522750A (ja) * 2009-04-01 2012-09-27 ビーエーエスエフ ソシエタス・ヨーロピア 無脊椎動物害虫を駆除するためのイソキサゾリン化合物
EP2417121A1 (en) 2009-04-10 2012-02-15 Pfizer Inc. 4, 5-dihydro-1h-pyrazole compounds and their pharmaceutical uses
GB0910003D0 (en) 2009-06-11 2009-07-22 Univ Leuven Kath Novel compounds for the treatment of neurodegenerative diseases
FR2948939B1 (fr) 2009-08-05 2013-03-22 Pf Medicament Derives de 2h pyridazin-3-ones, leur preparation et leur application en therapeutique humaine
TWI487486B (zh) * 2009-12-01 2015-06-11 Syngenta Participations Ag 以異唑啉衍生物為主之殺蟲化合物
GB2481118A (en) 2010-06-09 2011-12-14 Syngenta Participations Ag Pesticidal mixtures comprising enantiomerically enriched isoxazoline derivatives
KR20130089232A (ko) * 2010-06-15 2013-08-09 바이엘 인텔렉쳐 프로퍼티 게엠베하 안트라닐산 디아미드 유도체
DK178277B1 (da) 2010-06-18 2015-10-26 Novartis Tiergesundheit Ag Diaryloxazolinforbindelser til bekæmpelse af fiskelus
AU2012215440B2 (en) * 2011-02-10 2015-08-27 Novartis Tiergesundheit Ag Isoxazoline derivatives for controlling invertebrate pests

Similar Documents

Publication Publication Date Title
JP2014513122A5 (enExample)
US8901156B2 (en) Compounds and methods
RU2016102137A (ru) Первичные карбоксамиды в качестве ингибиторов bik
ES2629414T3 (es) Derivados de tiazol
US8981084B2 (en) Oxadiazole HDAC inhibitors
JP2017512794A5 (enExample)
JP2016523911A5 (enExample)
RU2016141646A (ru) Ингибиторы trka киназы, основанные на них композиции и способы
JP2020516671A5 (enExample)
JP2010533158A5 (enExample)
RU2019132212A (ru) Селективные ингибиторы hdac6
JP6500010B2 (ja) 新規ピリジン誘導体
JP2014525444A5 (enExample)
JP2018507234A5 (enExample)
JP2007510689A5 (enExample)
JP2021504443A5 (enExample)
JP2011503166A5 (enExample)
JP2007523142A5 (enExample)
JP2008501673A5 (enExample)
CA2630269A1 (en) Inhibitors of diacyglycerol acyltransferase (dgat)
JP2010540462A5 (enExample)
RU2015111133A (ru) Ингибиторы тирозинкиназы брутона
TW202045498A (zh) 作為法尼醇x受體調節劑之經取代雙環化合物
JP2017523223A5 (enExample)
RU2013152961A (ru) Изоксазолины в качестве терапевтических агентов